Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
Author:
Seshiru Nakazawa,Federica Pecci,Biagio Ricciuti,Felix H. Gottlieb,Francesco Facchinetti,Guilherme Harada,Monica F. Chen,Matteo Repetto,Flavia Giacomini,Jie Jiang,Marie-Anaïs Locquet,Maisam Makarem,Joao V. Alessi,Alessandro Di Federico,Mihaela Aldea et al.
Publication:
Journal of Thoracic Oncology
© 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.